Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Tert-butyl (3-tosyl-cyclobutyl)-carbamate is a carbamate derivative used as a building block in the pharmaceutical industry for synthesizing various drugs. It serves as a protecting group for amines in organic synthesis, with the tert-butyl group providing steric hindrance and the tosyl group allowing for selective deprotection under specific conditions. tert-butyl (3-tosyl-cyclobutyl)-carbamate is crucial for the efficient and selective synthesis of complex organic molecules and is utilized in the production of various therapeutic drugs.

878156-25-3

Post Buying Request

878156-25-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

878156-25-3 Usage

Uses

Used in Pharmaceutical Industry:
Tert-butyl (3-tosyl-cyclobutyl)-carbamate is used as a building block for the synthesis of various drugs, contributing to the development of new therapeutic agents.
Used as a Protecting Group in Organic Synthesis:
In organic synthesis, tert-butyl (3-tosyl-cyclobutyl)-carbamate is used as a protecting group for amines to prevent unwanted reactions, ensuring selective deprotection under specific conditions.
Used in the Production of Therapeutic Drugs:
Tert-butyl (3-tosyl-cyclobutyl)-carbamate plays a significant role in the efficient and selective synthesis of complex organic molecules, which are utilized in the production of various therapeutic drugs, enhancing their effectiveness and safety.

Check Digit Verification of cas no

The CAS Registry Mumber 878156-25-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,8,1,5 and 6 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 878156-25:
(8*8)+(7*7)+(6*8)+(5*1)+(4*5)+(3*6)+(2*2)+(1*5)=213
213 % 10 = 3
So 878156-25-3 is a valid CAS Registry Number.

878156-25-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Carbamic acid, N-[3-[[(4-methylphenyl)sulfonyl]oxy]cyclobutyl]-, 1,1-dimethylethyl ester

1.2 Other means of identification

Product number -
Other names Toluene-4-sulfonic acid 3-t-butoxycarbonylamino-cyclobutyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:878156-25-3 SDS

878156-25-3Relevant articles and documents

BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF

-

Paragraph 00204; 00225, (2021/02/12)

Provided herein are benzenesulfonamide derivatives having Formula (III), pharmaceutical compositions comprising said compounds, and method for using said compounds for disrupting proteins/polypeptides, protein/polypeptide function, and for the treatment of diseases through the disruption of proteins or polypeptides involved in the etiology of the disease. Said compounds comprise fluorinated benzene sulfonamide structures.

SUBSTITUTED 5-CYANOINDOLE COMPOUNDS AND USES THEREOF

-

Paragraph 00274; 00351, (2019/01/10)

A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1) - mediated diseases or disorders, Formula (I), wherein R1, R2, R3, R4, and R5 are as defined herein.

TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF

-

Paragraph 1158; 1159, (2017/01/23)

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.

2, 4-DIAMINOPYRIMIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER

-

Page/Page column 20, (2008/06/13)

The present invention encompasses compounds of general formula (1) wherein Q and R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, and the

2,4-DI(AMINOPHENYL) PYRIMIDINES AS PLK INHIBITORS

-

Page/Page column 48, (2008/06/13)

The invention relates to compounds of general formula (1), wherein A, W, X, Y, Z, Ra, Rb, Rc, R1, and R3 are defined as indicated in claim 1. Said compounds are used for the treatment of diseases characterized by excessive or anomalous cell proliferation. Also disclosed is the use of the inventive compounds for producing a medicament having said properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 878156-25-3